Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Molecular and Clinical Oncology|October 5, 2016
Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non-small-cell lung cancer patientsNikolaos Koufos, John Syrios, Despina Michailidou, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 13, 2022
Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort studySpyridon Xynogalos, David Simeonidis, George Papageorgiou, et al.International Journal of Computer Assisted Radiology and Surgery|November 28, 2016
Synchronized navigation of current and prior studies using image registration improves radiologist's efficiencyDaniel Forsberg, Amit Gupta, Christopher Mills, et al.Journal of Neuro-Oncology|June 14, 2002
Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancerChristos Kosmas, Nikolaos A Malamos, Nicolas B Tsavaris, et al.Pain Medicine (Malden, Mass.)|December 11, 2008
Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot studyNicolas Tsavaris, Petros Kopterides, Christos Kosmas, et al.Journal of Pain and Symptom Management|September 12, 2003
Amifostine, in a reduced dose, protects against severe diarrhea associated with weekly fluorouracil and folinic acid chemotherapy in advanced colorectal cancer: a pilot studyNicolas Tsavaris, Christos Kosmas, Maria Vadiaka, et al.Anti-Cancer Drugs|March 15, 2014
Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experienceChristos Kosmas, Aggelos Athanasopoulos, George Dimitriadis, et al.International Journal of Cancer|February 22, 2002
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancerChristos Kosmas, Nicolas B Tsavaris, Thomas Makatsoris, et al.Cancer Chemotherapy and Pharmacology|April 20, 2006
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimensChristos Kosmas, Nicolas Tsavaris, Konstantinos Syrigos, et al.PET Clinics|September 17, 2018
Applications of PET/CT and PET/MR Imaging in Primary Bone MalignanciesAshkan Heshmatzadeh Behzadi, Syed Imran Raza, John A Carrino, et al.Pageof 10